They come from universities, industry and research institutes in the U.S. and Europe and are leading experts in cardiovascular research: The Scientific Advisory Board of the German Centre for Cardiovascular Research (DZHK) convened in the head office in Berlin at the beginning of January for its constitutive meeting.
“The fact that these outstanding scientists dedicate their time to us shows the high expectations that are placed on us nationally and internationally,” said Thomas Eschenhagen, chairman of the board of the DZHK.
The Advisory Board members elected Garret A. FitzGerald as their chairman and Thomas Voit as vice chairman. At the end of an informative day, FitzGerald, speaking on behalf of the Advisory Board, praised the first-class research and the open atmosphere as well as the commitment of all participants involved in the DZHK. He also gave some preliminary recommendations about how the strategy of the DZHK should be developed further after the initial phase.
Members of the Scientific Advisory Board of the DZHK:
Garret A. FitzGerald, Institute for Translational Medicine and Therapeutics; Philadelphia, Pennsylvania, USA
Thomas Voit, Faculté de Médecine; Pierre et Marie Curie, Paris V; Paris, France
John McMurray, University of Glasgow; Scotland, United Kingdom
Susan Shurin, National Heart, Lung, and Blood Institute; Bethesda, Maryland, USA
Ramachandran Vasan, Boston University School of Medicine; Boston, Massachusetts, USA
Anna Dominiczak, University of Glasgow; Scotland, United Kingdom
Eduard C. Klasen, Leids Universitair Medisch Centrum; Leiden, The Netherlands
Frank Misselwitz, Bayer HealthCare Pharmaceuticals; Wuppertal, Germany
Andreas Barner, Boehringer Ingelheim GmbH; Ingelheim, Germany
Alan Daugherty, University of Kentucky; Lexington, Kentucky, USA
Frans Van de Werf, Katholieke Universität Leuven; Leuven, Belgium
Nigel Mackman, UNC School of Medicine; Chapel Hill, North Carolina, USA
German Centre for Cardiovascular Research
Press and Public Relations
phone: 030 4593 7102, email@example.com